Loading...

Dennis Black, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentEpidemiology & Biostatistics
Address550 16th. Street
San Francisco CA 94158
Phone415-514-8159
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    UCSF Core Center for Musculoskeletal Biology and Medicine
    NIH/NIAMS P30AR066262Jul 1, 2014 - Jun 30, 2019
    Role: Co-Investigator
    Trial Of Late SURFactant (TOLSURF) to Prevent BPD-Data Coordinating Center
    NIH U01HL094355Sep 15, 2009 - Jul 31, 2014
    Role: Principal Investigator
    PTH and ALDENRONATE COMBINATION TREATMENT OSTEOPOROSIS-264002245
    NIH N01AR002245Oct 27, 1999 - Oct 28, 2004
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Keller RL, Eichenwald EC, Hibbs AM, Rogers EE, Wai KC, Black D, Ballard PL, Asselin JM, Truog WE, Merrill JD, Mammel MC, Steinhorn RH, Ryan RM, Durand DJ, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, Helderman J, Porta NF, Wadhawan R, Palermo L, Ballard RA. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 Jan 16. PMID: 28100402.
      View in: PubMed
    2. Cummings SR, Cosman F, Lewiecki ME, Schousboe JT, Bauer D, Black D, Brown T, Cheung AM, Cody K, Cooper C, Diez-Perez A, Eastell R, Hadji P, Hosoi T, De Beur SJ, Kagan R, Kiel DP, Reid I, Solomon DH, Randall S. Goal-Directed Treatment for Osteoporosis: A Progress Report from the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis. J Bone Miner Res. 2016 Nov 19. PMID: 27864889.
      View in: PubMed
    3. Zhang AL, Sing DC, Dang DY, Ma CB, Black D, Vail TP, Feeley BT. Overlapping Surgery in the Ambulatory Orthopaedic Setting. J Bone Joint Surg Am. 2016 Nov 16; 98(22):1859-1867. PMID: 27852902.
      View in: PubMed
    4. Santoro N, Allshouse A, Neal-Perry G, Pal L, Lobo RA, Naftolin F, Black D, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Dunn M, Gleason CE, Hodis HN, Isaac B, Magnani M, Manson JE, Miller VM, Taylor HS, Wharton W, Wolff E, Zepeda V, Harman SM. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause. 2016 Oct 24. PMID: 27779568.
      View in: PubMed
    5. Cosman F, Hattersley G, Hu MY, Williams GC, Fitzpatrick LA, Black D. Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors. J Bone Miner Res. 2017 Jan; 32(1):17-23. PMID: 27612281.
      View in: PubMed
    6. Bonaretti S, Vilayphiou N, Chan CM, Yu A, Nishiyama K, Liu D, Boutroy S, Ghasem-Zadeh A, Boyd SK, Chapurlat R, McKay H, Shane E, Bouxsein ML, Black D, Majumdar S, Orwoll ES, Lang TF, Khosla S, Burghardt AJ, et al. Operator variability in scan positioning is a major component of HR-pQCT precision error and is reduced by standardized training. Osteoporos Int. 2016 Jul 30. PMID: 27475931.
      View in: PubMed
    7. Wai KC, Kohn MA, Ballard RA, Truog WE, Black D, Asselin JM, Ballard PL, Rogers EE, Keller RL. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. J Pediatr. 2016 Oct; 177:97-102.e2. PMID: 27470692; PMCID: PMC5037007 [Available on 10/01/17].
    8. Napoli N, Schafer AL, Lui LY, Cauley JA, Strotmeyer ES, Le Blanc ES, Hoffman AR, Lee CG, Black D, Schwartz AV. Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the Osteoporotic Fractures in Men (MrOS) study. Bone. 2016 Sep; 90:181-4. PMID: 27393241.
      View in: PubMed
    9. Black D, Rosen CJ. Postmenopausal Osteoporosis. N Engl J Med. 2016 May 26; 374(21):2096-7. PMID: 27223157.
      View in: PubMed
    10. Borggrefe J, de Buhr T, Shrestha S, Marshall LM, Orwoll E, Peters K, Black D, Glüer CC. Association of 3D Geometric Measures Derived From Quantitative Computed Tomography With Hip Fracture Risk in Older Men. J Bone Miner Res. 2016 Aug; 31(8):1550-8. PMID: 26916713.
      View in: PubMed
    11. van de Glind EM, Willems HC, Eslami S, Abu-Hanna A, Lems WF, Hooft L, de Rooij SE, Black D, van Munster BC. Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate. Drugs Aging. 2016 May; 33(5):347-53. PMID: 26884390.
      View in: PubMed
    12. Bell KJ, Hayen A, Glasziou P, Irwig L, Eastell R, Harrison SL, Black D, Bauer DC. Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data. J Bone Miner Res. 2016 Sep; 31(9):1767-73. PMID: 27027655.
      View in: PubMed
    13. Ensrud KE, Blackwell TL, Fink HA, Zhang J, Cauley JA, Cawthon PM, Black D, Bauer DC, Curtis JR, Orwoll ES, Barrett-Connor E, Kado DM, Marshall LM, Shikany JM, Schousboe JT. What Proportion of Incident Radiographic Vertebral Fractures in Older Men Is Clinically Diagnosed and Vice Versa: A Prospective Study. J Bone Miner Res. 2016 Aug; 31(8):1500-3. PMID: 26969847.
      View in: PubMed
    14. Cummings SR, Kiel DP, Black D. Vitamin D Supplementation and Increased Risk of Falling: A Cautionary Tale of Vitamin Supplements Retold. JAMA Intern Med. 2016 Feb 1; 176(2):171-2. PMID: 26746474.
      View in: PubMed
    15. Black D, Rosen CJ. Postmenopausal Osteoporosis. N Engl J Med. 2016 Jan 21; 374(3):254-62. PMID: 26789873.
      View in: PubMed
    16. Cawthon PM, Schousboe JT, Harrison SL, Ensrud KE, Black D, Cauley JA, Cummings SR, LeBlanc ES, Laughlin GA, Nielson CM, Broughton A, Kado DM, Hoffman AR, Jamal SA, Barrett-Connor E, Orwoll ES. Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone. 2016 Mar; 84:271-8. PMID: 26778261.
      View in: PubMed
    17. Miller VM, Jenkins GD, Biernacka JM, Heit JA, Huggins GS, Hodis HN, Budoff MJ, Lobo RA, Taylor HS, Manson JE, Black D, Naftolin F, Harman SM, de Andrade M. Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study. Physiol Genomics. 2016 Jan; 48(1):33-41. PMID: 26508701; PMCID: PMC4757027 [Available on 01/01/17].
    18. Ballard RA, Keller RL, Black D, Ballard PL, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn RH, Rogers EE, Ryan RM, Durand DJ, Asselin JM, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, O'Shea TM, Porta NF, Wadhawan R, Palermo L. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016 Jan; 168:23-29.e4. PMID: 26500107.
      View in: PubMed
    19. Ensrud KE, Blackwell TL, Cawthon PM, Bauer DC, Fink HA, Schousboe JT, Black D, Orwoll ES, Kado DM, Cauley JA, Mackey DC. Degree of Trauma Differs for Major Osteoporotic Fracture Events in Older Men Versus Older Women. J Bone Miner Res. 2016 Jan; 31(1):204-7. PMID: 26178795.
      View in: PubMed
    20. Treece GM, Gee AH, Tonkin C, Ewing SK, Cawthon PM, Black D, Poole KE. Predicting Hip Fracture Type With Cortical Bone Mapping (CBM) in the Osteoporotic Fractures in Men (MrOS) Study. J Bone Miner Res. 2015 Nov; 30(11):2067-77. PMID: 25982802; PMCID: PMC4657505.
    21. Gee AH, Treece GM, Tonkin CJ, Black D, Poole KE. Association between femur size and a focal defect of the superior femoral neck. Bone. 2015 Dec; 81:60-6. PMID: 26142930; PMCID: PMC4640978 [Available on 12/01/16].
    22. Szulc P, Blackwell T, Kiel DP, Schousboe JT, Cauley J, Hillier T, Hochberg M, Rodondi N, Taylor BC, Black D, Cummings S, Ensrud KE. Abdominal aortic calcification and risk of fracture among older women - The SOF study. Bone. 2015 Dec; 81:16-23. PMID: 26115911; PMCID: PMC4640997 [Available on 12/01/16].
    23. Cianferotti L, Parri S, Gronchi G, Rizzuti C, Fossi C, Black D, Brandi ML. Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset. Osteoporos Int. 2015 Nov; 26(11):2695-702. PMID: 26068296.
      View in: PubMed
    24. Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black D, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med. 2015 Jun; 12(6):e1001833; discussion e1001833. PMID: 26035291; PMCID: PMC4452757.
    25. Schafer AL, Weaver CM, Black D, Wheeler AL, Chang H, Szefc GV, Stewart L, Rogers SJ, Carter JT, Posselt AM, Shoback DM, Sellmeyer DE. Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status. J Bone Miner Res. 2015 Aug; 30(8):1377-85. PMID: 25640580; PMCID: PMC4593653 [Available on 08/01/16].
    26. Black D, Reid IR, Cauley JA, Cosman F, Leung PC, Lakatos P, Lippuner K, Cummings SR, Hue TF, Mukhopadhyay A, Tan M, Aftring RP, Eastell R. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2015 May; 30(5):934-44. PMID: 25545380.
      View in: PubMed
    27. Eastell R, Boonen S, Cosman F, Reid IR, Palermo L, Cummings SR, Black D. Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J Bone Miner Res. 2015 Mar; 30(3):570-4. PMID: 25214069.
      View in: PubMed
    28. Schafer AL, Li X, Schwartz AV, Tufts LS, Wheeler AL, Grunfeld C, Stewart L, Rogers SJ, Carter JT, Posselt AM, Black D, Shoback DM. Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study. Bone. 2015 May; 74:140-5. PMID: 25603463; PMCID: PMC4355193 [Available on 05/01/16].
    29. Cawthon PM, Haslam J, Fullman R, Peters KW, Black D, Ensrud KE, Cummings SR, Orwoll ES, Barrett-Connor E, Marshall L, Steiger P, Schousboe JT. Response to BONE-D-14-00884. Bone. 2015 Jun; 75:246. PMID: 25481408.
      View in: PubMed
    30. Cosman F, Cauley JA, Eastell R, Boonen S, Palermo L, Reid IR, Cummings SR, Black D. Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? J Clin Endocrinol Metab. 2014 Dec; 99(12):4546-54. PMID: 25215556.
      View in: PubMed
    31. Yang L, Palermo L, Black D, Eastell R. Prediction of incident hip fracture with the estimated femoral strength by finite element analysis of DXA Scans in the study of osteoporotic fractures. J Bone Miner Res. 2014 Dec; 29(12):2594-600. PMID: 24898426; PMCID: PMC4388249 [Available on 12/01/15].
    32. Cawthon PM, Blackwell TL, Marshall LM, Fink HA, Kado DM, Ensrud KE, Cauley JA, Black D, Orwoll ES, Cummings SR, Schousboe JT. Physical performance and radiographic and clinical vertebral fractures in older men. J Bone Miner Res. 2014 Sep; 29(9):2101-8. PMID: 25042072; PMCID: PMC4335673.
    33. McNabb B, Vittinghoff E, Eastell R, Schwartz AV, Bauer DC, Ensrud K, Barrett-Connor E, Black D. A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring. J Clin Endocrinol Metab. 2014 Nov; 99(11):4094-100. PMID: 25127011.
      View in: PubMed
    34. Hue TF, Cummings SR, Cauley JA, Bauer DC, Ensrud KE, Barrett-Connor E, Black D. Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid. JAMA Intern Med. 2014 Oct; 174(10):1550-7. PMID: 25111880; PMCID: PMC4398333.
    35. Harman SM, Black D, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014 Aug 19; 161(4):249-60. PMID: 25069991.
      View in: PubMed
    36. Cawthon PM, Haslam J, Fullman R, Peters KW, Black D, Ensrud KE, Cummings SR, Orwoll ES, Barrett-Connor E, Marshall L, Steiger P, Schousboe JT. Methods and reliability of radiographic vertebral fracture detection in older men: the osteoporotic fractures in men study. Bone. 2014 Oct; 67:152-5. PMID: 25003811; PMCID: PMC4152008.
    37. Bauer DC, Schwartz A, Palermo L, Cauley J, Hochberg M, Santora A, Cummings SR, Black D. Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study. JAMA Intern Med. 2014 Jul; 174(7):1126-34. PMID: 24798675; PMCID: PMC4409325.
    38. Ballard PL, Keller RL, Black D, Durand DJ, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn R, Ryan RM, Courtney SE, Horneman H, Ballard RA. Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome. Am J Perinatol. 2015 Feb; 32(3):225-32. PMID: 24968129.
      View in: PubMed
    39. Napoli N, Strotmeyer ES, Ensrud KE, Sellmeyer DE, Bauer DC, Hoffman AR, Dam TT, Barrett-Connor E, Palermo L, Orwoll ES, Cummings SR, Black D, Schwartz AV. Fracture risk in diabetic elderly men: the MrOS study. Diabetologia. 2014 Oct; 57(10):2057-65. PMID: 24908567; PMCID: PMC4344350.
    40. Szulc P, Blackwell T, Schousboe JT, Bauer DC, Cawthon P, Lane NE, Cummings SR, Orwoll ES, Black D, Ensrud KE. High hip fracture risk in men with severe aortic calcification: MrOS study. J Bone Miner Res. 2014 Apr; 29(4):968-75. PMID: 23983224; PMCID: PMC3935989.
    41. Schousboe JT, Rosen HR, Vokes TJ, Cauley JA, Cummings SR, Nevitt M, Black D, Orwoll ES, Kado DM, Ensrud KE. Prediction models of prevalent radiographic vertebral fractures among older women. J Clin Densitom. 2014 Jul-Sep; 17(3):378-85. PMID: 24582085; PMCID: PMC4119570.
    42. Schafer AL, Napoli N, Lui L, Schwartz AV, Black D. Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women. Diabet Med. 2014 May; 31(5):564-9. PMID: 24299116; PMCID: PMC3988213.
    43. Wharton W, Gleason CE, Dowling NM, Carlsson CM, Brinton EA, Santoro MN, Neal-Perry G, Taylor H, Naftolin F, Lobo RA, Merriam G, Manson JE, Cedars MI, Miller VM, Black D, Budoff M, Hodis HN, Harman SM, Asthana S. The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis. 2014; 40(2):331-41. PMID: 24430001; PMCID: PMC4367860.
    44. Schousboe JT, Rosen HR, Vokes TJ, Cauley JA, Cummings SR, Nevitt MC, Black D, Orwoll ES, Kado DM, Ensrud KE. Prediction models of prevalent radiographic vertebral fractures among older men. J Clin Densitom. 2014 Oct-Dec; 17(4):449-57. PMID: 24289883; PMCID: PMC4035457.
    45. Black D, Schafer AL. The search for the optimal anabolic osteoporosis therapy. J Bone Miner Res. 2013 Nov; 28(11):2263-5. PMID: 24115189.
      View in: PubMed
    46. Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LY, Wallace RB, Cummings SR, Black D, Bauer DC, Reid IR. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res. 2013 Jun; 28(6):1348-54. PMID: 23322676.
      View in: PubMed
    47. McNabb BL, Vittinghoff E, Schwartz AV, Eastell R, Bauer DC, Ensrud K, Rosenberg E, Santora A, Barrett-Connor E, Black D. BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate. J Bone Miner Res. 2013 Jun; 28(6):1319-27. PMID: 23408577.
      View in: PubMed
    48. Schwartz AV, Ewing SK, Porzig AM, McCulloch CE, Resnick HE, Hillier TA, Ensrud KE, Black D, Nevitt MC, Cummings SR, Sellmeyer DE. Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women. Front Endocrinol (Lausanne). 2013; 4:62. PMID: 23755040; PMCID: PMC3667237.
    49. Schafer AL, Burghardt AJ, Sellmeyer DE, Palermo L, Shoback DM, Majumdar S, Black D. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS). Osteoporos Int. 2013 Oct; 24(10):2591-601. PMID: 23589163.
      View in: PubMed
    50. Napoli N, Schwartz AV, Palermo L, Jin JJ, Wustrack R, Cauley JA, Ensrud KE, Kelly M, Black D. Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J Clin Endocrinol Metab. 2013 Feb; 98(2):659-67. PMID: 23345099; PMCID: PMC3565107.
    51. Wolff EF, He Y, Black D, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Zhang H, Harman SM, Taylor HS. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril. 2013 Apr; 99(5):1385-91. PMID: 23312232; PMCID: PMC3615128.
    52. Reid IR, Black D, Eastell R, Bucci-Rechtweg C, Su G, Hue TF, Mesenbrink P, Lyles KW, Boonen S. Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. J Clin Endocrinol Metab. 2013 Feb; 98(2):557-63. PMID: 23293335.
      View in: PubMed
    53. Yang L, Sycheva AV, Black D, Eastell R. Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial. Osteoporos Int. 2013 Jan; 24(1):329-38. PMID: 23128664.
      View in: PubMed
    54. Keller RL, Merrill JD, Black D, Steinhorn RH, Eichenwald EC, Durand DJ, Ryan RM, Truog WE, Courtney SE, Ballard PL, Ballard RA. Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study. Pediatr Res. 2012 Dec; 72(6):613-9. PMID: 23037875; PMCID: PMC3548137.
    55. Black D, Bilezikian JP, Greenspan SL, Wüster C, Muñoz-Torres M, Bone HG, Rosen CJ, Andersen HS, Hanley DA. Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis. Osteoporos Int. 2013 Apr; 24(4):1503-11. PMID: 22930240.
      View in: PubMed
    56. Jacques RM, Boonen S, Cosman F, Reid IR, Bauer DC, Black D, Eastell R. Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012 Aug; 27(8):1627-34. PMID: 22532515.
      View in: PubMed
    57. Schafer AL, Sellmeyer DE, Palermo L, Hietpas J, Eastell R, Shoback DM, Black D. Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial. J Clin Endocrinol Metab. 2012 Oct; 97(10):3522-9. PMID: 22791766; PMCID: PMC3674294.
    58. Boonen S, Eastell R, Su G, Mesenbrink P, Cosman F, Cauley JA, Reid IR, Claessens F, Vanderschueren D, Lyles KW, Black D. Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. J Bone Miner Res. 2012 Jul; 27(7):1487-93. PMID: 22431413; PMCID: PMC3636532.
    59. Piscitelli P, Chitano G, Johannson H, Brandi ML, Kanis JA, Black D. Updated fracture incidence rates for the Italian version of FRAX®. Osteoporos Int. 2013 Mar; 24(3):859-66. PMID: 22638710.
      View in: PubMed
    60. Rosen CJ, Adams JS, Bikle DD, Black D, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012 Jun; 33(3):456-92. PMID: 22596255; PMCID: PMC3365859.
    61. Black D, Bauer DC, Schwartz AV, Cummings SR, Rosen CJ. Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? N Engl J Med. 2012 May 31; 366(22):2051-3. PMID: 22571169; PMCID: PMC4015798.
    62. Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E. Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res. 2012 May; 27(5):977-86. PMID: 22275107.
      View in: PubMed
    63. Napoli N, Jin J, Peters K, Wustrack R, Burch S, Chau A, Cauley J, Ensrud K, Kelly M, Black D. Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures. J Clin Endocrinol Metab. 2012 Jul; 97(7):2414-22. PMID: 22547423; PMCID: PMC3387394.
    64. Black D, Rosen CJ. Following the bone density trail: a clinical perspective. J Clin Endocrinol Metab. 2012 Apr; 97(4):1176-8. PMID: 22493309.
      View in: PubMed
    65. Wang X, Sanyal A, Cawthon PM, Palermo L, Jekir M, Christensen J, Ensrud KE, Cummings SR, Orwoll E, Black D, Keaveny TM. Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. J Bone Miner Res. 2012 Apr; 27(4):808-16. PMID: 22190331; PMCID: PMC3510751.
    66. Black D, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RL, Tan M, Ruzycky ME, Su G, Eastell R. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012 Feb; 27(2):243-54. PMID: 22161728; PMCID: PMC3427916.
    67. Hillier TA, Lui LY, Kado DM, LeBlanc ES, Vesco KK, Bauer DC, Cauley JA, Ensrud KE, Black D, Hochberg MC, Cummings SR. Height loss in older women: risk of hip fracture and mortality independent of vertebral fractures. J Bone Miner Res. 2012 Jan; 27(1):153-9. PMID: 22072593; PMCID: PMC3622730.
    68. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black D. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab. 2011 Dec; 96(12):E1982-9. PMID: 21994958; PMCID: PMC3232610.
    69. Mackey DC, Black D, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR. Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res. 2011 Oct; 26(10):2411-8. PMID: 21710615.
      View in: PubMed
    70. LeBlanc ES, Hillier TA, Pedula KL, Rizzo JH, Cawthon PM, Fink HA, Cauley JA, Bauer DC, Black D, Cummings SR, Browner WS. Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med. 2011 Nov 14; 171(20):1831-7. PMID: 21949033; PMCID: PMC3576923.
    71. Hillier TA, Cauley JA, Rizzo JH, Pedula KL, Ensrud KE, Bauer DC, Lui LY, Vesco KK, Black D, Donaldson MG, Leblanc ES, Cummings SR. WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis? J Bone Miner Res. 2011 Aug; 26(8):1774-82. PMID: 21351144; PMCID: PMC3622725.
    72. Wustrack R, Seeman E, Bucci-Rechtweg C, Burch S, Palermo L, Black D. Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial. Osteoporos Int. 2012 Jan; 23(1):53-8. PMID: 21691843.
      View in: PubMed
    73. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black D. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011 Jun 1; 305(21):2184-92. PMID: 21632482; PMCID: PMC3287389.
    74. Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, Man Z, Hadji P, Reid IR. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. J Bone Miner Res. 2011 May; 26(5):984-92. PMID: 21542001.
      View in: PubMed
    75. Curtis JR, Delzell E, Chen L, Black D, Ensrud K, Judd S, Safford MM, Schwartz AV, Bauer DC. The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res. 2011 Apr; 26(4):683-8. PMID: 20939064; PMCID: PMC3179329.
    76. Li X, Kuo D, Schafer AL, Porzig A, Link TM, Black D, Schwartz AV. Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging. 2011 Apr; 33(4):974-9. PMID: 21448966; PMCID: PMC3072841.
    77. Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black D. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab. 2011 Jun; 96(6):1627-32. PMID: 21430030.
      View in: PubMed
    78. Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, Boonen S, Black D, Adachi JD. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone. 2011 Jun 1; 48(6):1298-304. PMID: 21421092.
      View in: PubMed
    79. Harman SM, Vittinghoff E, Brinton EA, Budoff MJ, Cedars MI, Lobo RA, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Taylor HS, Black D. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med. 2011 Mar; 124(3):199-205. PMID: 21396500; PMCID: PMC3107840.
    80. Katzman WB, Vittinghoff E, Ensrud K, Black D, Kado DM. Increasing kyphosis predicts worsening mobility in older community-dwelling women: a prospective cohort study. J Am Geriatr Soc. 2011 Jan; 59(1):96-100. PMID: 21198460; PMCID: PMC3696343.
    81. Gamsjaeger S, Buchinger B, Zwettler E, Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid. J Bone Miner Res. 2011 Jan; 26(1):12-8. PMID: 20645415.
      View in: PubMed
    82. Schafer AL, Palermo L, Bauer DC, Bilezikian JP, Sellmeyer DE, Black D. Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis. J Clin Densitom. 2011 Jan-Mar; 14(1):68-73. PMID: 21095149.
      View in: PubMed
    83. Grbic JT, Black D, Lyles KW, Reid DM, Orwoll E, McClung M, Bucci-Rechtweg C, Su G. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc. 2010 Nov; 141(11):1365-70. PMID: 21037195.
      View in: PubMed
    84. Diederichs G, Engelken F, Marshall LM, Peters K, Black D, Issever AS, Barrett-Connor E, Orwoll E, Hamm B, Link TM. Diffuse idiopathic skeletal hyperostosis (DISH): relation to vertebral fractures and bone density. Osteoporos Int. 2011 Jun; 22(6):1789-97. PMID: 20882271; PMCID: PMC3092929.
    85. Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Dam TT, Curtis JR, Black D, Bauer DC, Orwoll ES, Cummings SR. Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines. J Bone Miner Res. 2010 Jul; 25(7):1506-11. PMID: 20200971; PMCID: PMC3153995.
    86. Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black D. Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab. 2010 Sep; 95(9):4380-7. PMID: 20554708.
      View in: PubMed
    87. Schwartz AV, Bauer DC, Cummings SR, Cauley JA, Ensrud KE, Palermo L, Wallace RB, Hochberg MC, Feldstein AC, Lombardi A, Black D. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res. 2010 May; 25(5):976-82. PMID: 20200926.
      View in: PubMed
    88. Black D, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010 May 13; 362(19):1761-71. PMID: 20335571.
      View in: PubMed
    89. Boonen S, Black D, Colón-Emeric CS, Eastell R, Magaziner JS, Eriksen EF, Mesenbrink P, Haentjens P, Lyles KW. Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc. 2010 Feb; 58(2):292-9. PMID: 20070415; PMCID: PMC3660706.
    90. Hibbs AM, Black D, Palermo L, Cnaan A, Luan X, Truog WE, Walsh MC, Ballard RA. Accounting for multiple births in neonatal and perinatal trials: systematic review and case study. J Pediatr. 2010 Feb; 156(2):202-8. PMID: 19969305; PMCID: PMC2844328.
    91. Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black D, Ballard PL, Wadlinger SR, Ballard RA. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics. 2009 Nov; 124(5):1325-32. PMID: 19841125.
      View in: PubMed
    92. Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black D. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial. Osteoporos Int. 2010 Jul; 21(7):1277-85. PMID: 19802508.
      View in: PubMed
    93. Delmas PD, Munoz F, Black D, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis. J Bone Miner Res. 2009 Sep; 24(9):1544-51. PMID: 19338427.
      View in: PubMed
    94. Ettinger B, Black D, Dawson-Hughes B, Pressman AR, Melton LJ. Updated fracture incidence rates for the US version of FRAX. Osteoporos Int. 2010 Jan; 21(1):25-33. PMID: 19705048; PMCID: PMC2788143.
    95. Eastell R, Black D, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab. 2009 Sep; 94(9):3215-25. PMID: 19567517.
      View in: PubMed
    96. Miller VM, Black D, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Naftolin F, Santoro N, Taylor HS, Harman SM. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res. 2009 Sep; 2(3):228-39. PMID: 19668346.
      View in: PubMed
    97. Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black D, Cummings SR, Harris TB, Bauer DC. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009 Jul; 94(7):2380-6. PMID: 19383780; PMCID: PMC2708944.
    98. Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Black D, Bauer DC, Cummings SR. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009 Apr; 24(4):675-80. PMID: 19049330; PMCID: PMC2659514.
    99. Prevrhal S, Krege JH, Chen P, Genant H, Black D. Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment. Curr Med Res Opin. 2009 Apr; 25(4):921-8. PMID: 19250060.
      View in: PubMed
    100. Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, Cauley JA, Black D, Delmas PD, Eastell R. Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res. 2009 Mar; 24(3):389-97. PMID: 18665786.
      View in: PubMed
    101. Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black D. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008 Dec; 23(12):1974-82. PMID: 18684084; PMCID: PMC2686921.
    102. Antoniucci DM, Vittinghoff E, Palermo L, Black D, Sellmeyer DE. Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int. 2009 Jul; 20(7):1259-66. PMID: 19043656.
      View in: PubMed
    103. Garnero P, Bauer DC, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, Black D. Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Miner Res. 2008 Sep; 23(9):1442-8. PMID: 18442311; PMCID: PMC2683159.
    104. Cauley JA, Palermo L, Vogt M, Ensrud KE, Ewing S, Hochberg M, Nevitt MC, Black D. Prevalent vertebral fractures in black women and white women. J Bone Miner Res. 2008 Sep; 23(9):1458-67. PMID: 18442309; PMCID: PMC2683160.
    105. Black D, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res. 2008 Aug; 23(8):1326-33. PMID: 18348697; PMCID: PMC2680175.
    106. Black D, Boonen S, Delmas P, Lyles KW. Review of comparative effectiveness of treatments to prevent fractures. Ann Intern Med. 2008 Jun 3; 148(11):885-6; author reply 887. PMID: 18519940.
      View in: PubMed
    107. Truog WE, Martin RJ, Ballard RA, Black D, Cnaan A. Inhaled nitric oxide for preterm infants. Pediatrics. 2008 Jun; 121(6):1287-8; author reply 1288-9. PMID: 18519502.
      View in: PubMed
    108. Black D, Bouxsein ML, Palermo L, McGowan JA, Newitt DC, Rosen E, Majumdar S, Rosen CJ. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling. J Clin Endocrinol Metab. 2008 Jun; 93(6):2166-72. PMID: 18349061; PMCID: PMC2435646.
    109. Prevrhal S, Shepherd JA, Faulkner KG, Gaither KW, Black D, Lang TF. Comparison of DXA hip structural analysis with volumetric QCT. J Clin Densitom. 2008 Apr-Jun; 11(2):232-6. PMID: 18280192.
      View in: PubMed
    110. Ferrar L, Jiang G, Cawthon PM, San Valentin R, Fullman R, Lambert L, Cummings SR, Black D, Orwoll E, Barrett-Connor E, Ensrud K, Fink HA, Eastell R. Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study. J Bone Miner Res. 2007 Sep; 22(9):1434-41. PMID: 17563237.
      View in: PubMed
    111. Black D, Rosen CJ. Is risedronate or alendronate more effective at preventing nonvertebral fractures in women with osteoporosis? Nat Clin Pract Rheumatol. 2007 Jul; 3(7):378-9. PMID: 17549088.
      View in: PubMed
    112. Cummings SR, Schwartz AV, Black D. Alendronate and atrial fibrillation. N Engl J Med. 2007 May 3; 356(18):1895-6. PMID: 17476024.
      View in: PubMed
    113. Black D, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007 May 3; 356(18):1809-22. PMID: 17476007.
      View in: PubMed
    114. Sellmeyer DE, Black D, Palermo L, Greenspan S, Ensrud K, Bilezikian J, Rosen CJ. Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis. Osteoporos Int. 2007 Jul; 18(7):973-9. PMID: 17333451.
      View in: PubMed
    115. Black D, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006 Dec 27; 296(24):2927-38. PMID: 17190893.
      View in: PubMed
    116. Antoniucci DM, Sellmeyer DE, Bilezikian JP, Palermo L, Ensrud KE, Greenspan SL, Black D. Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis. J Clin Endocrinol Metab. 2007 Mar; 92(3):942-7. PMID: 17164314; PMCID: PMC3746103.
    117. LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006 Sep; 44(3):746-64. PMID: 16941705.
      View in: PubMed
    118. Jamal SA, Hamilton CJ, Black D, Cummings SR. The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. Trials. 2006; 7:10. PMID: 16640783; PMCID: PMC1471803.
    119. Bauer DC, Garnero P, Bilezikian JP, Greenspan SL, Ensrud KE, Rosen CJ, Palermo L, Black D. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2006 Apr; 91(4):1370-5. PMID: 16449339.
      View in: PubMed
    120. Black D, Palermo L, Grima DT. Developing better economic models of osteoporosis: considerations for the calculation of the relative risk of fracture. Value Health. 2006 Jan-Feb; 9(1):54-8. PMID: 16441525.
      View in: PubMed
    121. Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black D. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res. 2006 Feb; 21(2):292-9. PMID: 16418785.
      View in: PubMed
    122. Black D, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med. 2005 Aug 11; 353(6):555-65. PMID: 16093464.
      View in: PubMed
    123. Antoniucci DM, Vittinghoff E, Blackwell T, Black D, Sellmeyer DE. Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab. 2005 Aug; 90(8):4566-72. PMID: 15899959.
      View in: PubMed
    124. Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK, Black D, Ensrud KE. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res. 2005 Jul; 20(7):1216-22. PMID: 15940375.
      View in: PubMed
    125. Quandt SA, Thompson DE, Schneider DL, Nevitt MC, Black D. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005 Mar; 80(3):343-9. PMID: 15757015.
      View in: PubMed
    126. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black D, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005 May; 90(5):2787-93. PMID: 15728213.
      View in: PubMed
    127. Hochberg MC, Thompson DE, Black D, Quandt SA, Cauley J, Geusens P, Ross PD, Baran D. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005 Jun; 20(6):971-6. PMID: 15883637.
      View in: PubMed
    128. Antoniucci DM, Black D, Sellmeyer DE. Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. Clin Chem. 2005 Jan; 51(1):258-61. PMID: 15613728.
      View in: PubMed
    129. Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black D, Cauley JA, Cummings SR, Harris TB. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005 Apr; 20(4):596-603. PMID: 15765178.
      View in: PubMed
    130. Reid IR, Gamble GD, Grey AB, Black D, Ensrud KE, Browner WS, Bauer DC. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res. 2005 Apr; 20(4):613-8. PMID: 15765180.
      View in: PubMed
    131. Jin H, Lu Y, Stone K, Black D. Alternative tree-structured survival analysis based on variance of survival time. Med Decis Making. 2004 Nov-Dec; 24(6):670-80. PMID: 15534347.
      View in: PubMed
    132. Nevitt MC, Cummings SR, Stone KL, Palermo L, Black D, Bauer DC, Genant HK, Hochberg MC, Ensrud KE, Hillier TA, Cauley JA. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res. 2005 Jan; 20(1):131-40. PMID: 15619679.
      View in: PubMed
    133. Jin H, Lu Y, Harris ST, Black D, Stone K, Hochberg MC, Genant HK. Classification algorithms for hip fracture prediction based on recursive partitioning methods. Med Decis Making. 2004 Jul-Aug; 24(4):386-98. PMID: 15271277.
      View in: PubMed
    134. Bauer DC, Black D, Garnero P, Hochberg M, Ott S, Orloff J, Thompson DE, Ewing SK, Delmas PD. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res. 2004 Aug; 19(8):1250-8. PMID: 15231011.
      View in: PubMed
    135. Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black D. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res. 2004 Aug; 19(8):1259-69. PMID: 15231012.
      View in: PubMed
    136. Johnell O, Kanis JA, Black D, Balogh A, Poor G, Sarkar S, Zhou C, Pavo I. Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J Bone Miner Res. 2004 May; 19(5):764-72. PMID: 15068500.
      View in: PubMed
    137. Bauer DC, Mundy GR, Jamal SA, Black D, Cauley JA, Ensrud KE, van der Klift M, Pols HA. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med. 2004 Jan 26; 164(2):146-52. PMID: 14744837.
      View in: PubMed
    138. Rosen CJ, Black D, Greenspan SL. Vignettes in osteoporosis: a road map to successful therapeutics. J Bone Miner Res. 2004 Jan; 19(1):3-10. PMID: 14753730.
      View in: PubMed
    139. Cauley JA, Zmuda JM, Wisniewski SR, Krishnaswami S, Palermo L, Stone KL, Black D, Nevitt MC. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos Int. 2004 Jan; 15(1):32-7. PMID: 14628107.
      View in: PubMed
    140. Black D, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003 Sep 25; 349(13):1207-15. PMID: 14500804.
      View in: PubMed
    141. Kanis JA, Johnell O, Black D, Downs RW, Sarkar S, Fuerst T, Secrest RJ, Pavo I. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone. 2003 Sep; 33(3):293-300. PMID: 13678769.
      View in: PubMed
    142. Varosy PD, Shlipak MG, Vittinghoff E, Black D, Herrington D, Hulley SB, Browner WS. Fracture and the risk of coronary events in women with heart disease. Am J Med. 2003 Aug 15; 115(3):196-202. PMID: 12935826.
      View in: PubMed
    143. Siris ES, Bilezikian JP, Rubin MR, Black D, Bockman RS, Bone HG, Hochberg MC, McClung MR, Schnitzer TJ. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003 Aug; 88(8):3482-6. PMID: 12915621.
      View in: PubMed
    144. Johnell O, Jönsson B, Jönsson L, Black D. Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures. Pharmacoeconomics. 2003; 21(5):305-14. PMID: 12627984.
      View in: PubMed
    145. Cummings SR, Bates D, Black D. Clinical use of bone densitometry: scientific review. JAMA. 2002 Oct 16; 288(15):1889-97. PMID: 12377088.
      View in: PubMed
    146. Bates DW, Black D, Cummings SR. Clinical use of bone densitometry: clinical applications. JAMA. 2002 Oct 16; 288(15):1898-900. PMID: 12377089.
      View in: PubMed
    147. Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, Schreiner PJ, Margolis KL, Cauley JA, Nevitt MC, Black D, Cummings SR. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care. 2002 Oct; 25(10):1749-54. PMID: 12351472.
      View in: PubMed
    148. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black D, Eastell R. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002 Aug; 87(8):3609-17. PMID: 12161484.
      View in: PubMed
    149. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, Black D, Adachi J, Shea B, Tugwell P, Guyatt G. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev. 2002 Aug; 23(4):508-16. PMID: 12202465.
      View in: PubMed
    150. Bouxsein ML, Palermo L, Yeung C, Black D. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporos Int. 2002 May; 13(5):358-65. PMID: 12086345.
      View in: PubMed
    151. Black D, Wagman RB. Identifying fracture risk in postmenopausal women. JAMA. 2002 Mar 6; 287(9):1109; author reply 1110. PMID: 11879095.
      View in: PubMed
    152. Levis S, Quandt SA, Thompson D, Scott J, Schneider DL, Ross PD, Black D, Suryawanshi S, Hochberg M, Yates J. Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial. J Am Geriatr Soc. 2002 Mar; 50(3):409-15. PMID: 11943033.
      View in: PubMed
    153. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black D. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002 Mar; 112(4):281-9. PMID: 11893367.
      View in: PubMed
    154. Sarkar S, Mitlak BH, Wong M, Stock JL, Black D, Harper KD. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002 Jan; 17(1):1-10. PMID: 11771654.
      View in: PubMed
    155. Pedro-Botet J, Schaefer EJ, Bakker-Arkema RG, Black D, Stein EM, Corella D, Ordovas JM. Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis. 2001 Sep; 158(1):183-93. PMID: 11500190.
      View in: PubMed
    156. Cauley JA, Black D, Barrett-Connor E, Harris F, Shields K, Applegate W, Cummings SR. Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med. 2001 Apr 15; 110(6):442-50. PMID: 11331055.
      View in: PubMed
    157. Chrischilles EA, Dasbach EJ, Rubenstein LM, Cook JR, Tabor HK, Black D. The effect of alendronate on fracture-related healthcare utilization and costs: the fracture intervention trial. Osteoporos Int. 2001; 12(8):654-60. PMID: 11580079.
      View in: PubMed
    158. Tosteson AN, Jönsson B, Grima DT, O'Brien BJ, Black D, Adachi JD. Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int. 2001; 12(10):849-57. PMID: 11716188.
      View in: PubMed
    159. Black D, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001; 12(7):519-28. PMID: 11527048.
      View in: PubMed
    160. Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black D, Cummings SR. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001 Jan; 86(1):32-8. PMID: 11231974.
      View in: PubMed
    161. Black D, Palermo L, Sørensen T, Jørgensen JT, Lewis C, Tylavsky F, Wallace R, Harris E, Cummings SR. A normative reference database study for Pronosco X-posure System. J Clin Densitom. 2001; 4(1):5-12. PMID: 11393145.
      View in: PubMed
    162. Black D, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000 Nov; 85(11):4118-24. PMID: 11095442.
      View in: PubMed
    163. Black D, Cooper C. Epidemiology of fractures and assessment of fracture risk. Clin Lab Med. 2000 Sep; 20(3):439-53. PMID: 10986614.
      View in: PubMed
    164. Buist DS, LaCroix AZ, Black D, Harris F, Blank J, Ensrud K, Edgerton D, Rubin S, Fox KM. Inclusion of older women in randomized clinical trials: factors associated with taking study medication in the fracture intervention trial. J Am Geriatr Soc. 2000 Sep; 48(9):1126-31. PMID: 10983914.
      View in: PubMed
    165. Isaacsohn JL, Davidson MH, Hunninghake D, Singer R, McLain R, Black D. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease. Am J Cardiol. 2000 Jul 15; 86(2):250-2. PMID: 10913499.
      View in: PubMed
    166. Ensrud KE, Thompson DE, Cauley JA, Nevitt MC, Kado DM, Hochberg MC, Santora AC, Black D. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc. 2000 Mar; 48(3):241-9. PMID: 10733048.
      View in: PubMed
    167. Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, Black D, Kuller LH. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss. J Bone Miner Res. 2000 Feb; 15(2):308-14. PMID: 10703933.
      View in: PubMed
    168. Nevitt MC, Thompson DE, Black D, Rubin SR, Ensrud K, Yates AJ, Cummings SR. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med. 2000 Jan 10; 160(1):77-85. PMID: 10632308.
      View in: PubMed
    169. Ettinger B, Black D, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999 Aug 18; 282(7):637-45. PMID: 10517716.
      View in: PubMed
    170. Bauer DC, Sklarin PM, Stone KL, Black D, Nevitt MC, Ensrud KE, Arnaud CD, Genant HK, Garnero P, Delmas PD, Lawaetz H, Cummings SR. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res. 1999 Aug; 14(8):1404-10. PMID: 10457273.
      View in: PubMed
    171. May GH, Harris F, Gillespie D, Black D. The BRCA2 transactivation domain does not interact with JNK. Genes Chromosomes Cancer. 1999 Aug; 25(4):407-9. PMID: 10398438.
      View in: PubMed
    172. Salamone LM, Cauley JA, Black D, Simkin-Silverman L, Lang W, Gregg E, Palermo L, Epstein RS, Kuller LH, Wing R. Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr. 1999 Jul; 70(1):97-103. PMID: 10393145.
      View in: PubMed
    173. Black D, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999 May; 14(5):821-8. PMID: 10320531.
      View in: PubMed
    174. Black D, Thompson DE. The effect of alendronate therapy on osteoporotic fracture in the vertebral fracture arm of the Fracture Intervention Trial. Int J Clin Pract Suppl. 1999 Apr; 101:46-50. PMID: 12669740.
      View in: PubMed
    175. Black D. The role of clinical risk factors in the prediction of future risk. J Clin Densitom. 1999; 2(4):361-2. PMID: 10677788.
      View in: PubMed
    176. Black D, Palermo L, Nevitt MC, Genant HK, Christensen L, Cummings SR. Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999 Jan; 14(1):90-101. PMID: 9893070.
      View in: PubMed
    177. Cummings SR, Black D, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998 Dec 23-30; 280(24):2077-82. PMID: 9875874.
      View in: PubMed
    178. Hunninghake D, Bakker-Arkema RG, Wigand JP, Drehobl M, Schrott H, Early JL, Abdallah P, McBride S, Black D. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease. J Fam Pract. 1998 Nov; 47(5):349-56. PMID: 9834769.
      View in: PubMed
    179. Stone K, Bauer DC, Black D, Sklarin P, Ensrud KE, Cummings SR. Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1998 Jul; 13(7):1167-74. PMID: 9661081.
      View in: PubMed
    180. Herrington DM, Fong J, Sempos CT, Black D, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III) Am Heart J. 1998 Jul; 136(1):115-24. PMID: 9665228.
      View in: PubMed
    181. Nevitt MC, Ettinger B, Black D, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998 May 15; 128(10):793-800. PMID: 9599190.
      View in: PubMed
    182. Shepherd J, Olsson AG, Sacks FM, Black D, Orloff DG, Bilheimer DW. Should separate endpoint trials be required for all lipid-lowering drugs acting by the same mechanism? Am J Cardiol. 1998 Apr 23; 81(8A):88F-94F. PMID: 9604922.
      View in: PubMed
    183. Black D, Bakker-Arkema RG, Nawrocki JW. An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor. Arch Intern Med. 1998 Mar 23; 158(6):577-84. PMID: 9521221.
      View in: PubMed
    184. McKenney JM, McCormick LS, Weiss S, Koren M, Kafonek S, Black D. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group. Am J Med. 1998 Feb; 104(2):137-43. PMID: 9528731.
      View in: PubMed
    185. Ensrud KE, Black D, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA, Thompson DE, Karpf DB. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med. 1997 Dec 8-22; 157(22):2617-24. PMID: 9531231.
      View in: PubMed
    186. Ooi TC, Heinonen T, Alaupovic P, Davignon J, Leiter L, Lupien PJ, Sniderman AD, Tan MH, Tremblay G, Sorisky A, Shurzinske L, Black D. Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate. Arterioscler Thromb Vasc Biol. 1997 Sep; 17(9):1793-9. PMID: 9327779.
      View in: PubMed
    187. Ensrud KE, Black D, Harris F, Ettinger B, Cummings SR. Correlates of kyphosis in older women. The Fracture Intervention Trial Research Group. J Am Geriatr Soc. 1997 Jun; 45(6):682-7. PMID: 9180660.
      View in: PubMed
    188. Bauer DC, Glüer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black D. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1997 Mar 24; 157(6):629-34. PMID: 9080917.
      View in: PubMed
    189. Black D, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996 Dec 7; 348(9041):1535-41. PMID: 8950879.
      View in: PubMed
    190. Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD, Balagtas CC, Rowan JP, Black D. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Atherosclerosis. 1996 Nov 15; 127(1):113-22. PMID: 9006811.
      View in: PubMed
    191. Salamone LM, Glynn NW, Black D, Ferrell RE, Palermo L, Epstein RS, Kuller LH, Cauley JA. Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res. 1996 Oct; 11(10):1557-65. PMID: 8889857.
      View in: PubMed
    192. Brown JS, Seeley DG, Fong J, Black D, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol. 1996 May; 87(5 Pt 1):715-21. PMID: 8677073.
      View in: PubMed
    193. Black D. Screening and treatment in the elderly to reduce osteoporotic fracture risk. Br J Obstet Gynaecol. 1996 May; 103 Suppl 13:2-7; discussion 7-8. PMID: 8624337.
      View in: PubMed
    194. Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, Keilson LM, Brown WV, Miller VT, Shurzinske LJ, Black D. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA. 1996 Jan 10; 275(2):128-33. PMID: 8531308.
      View in: PubMed
    195. Salamone LM, Ferrell R, Black D, Palermo L, Epstein RS, Petro N, Steadman N, Kuller LH, Cauley JA. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int. 1996; 6(1):63-8. PMID: 8845602.
      View in: PubMed
    196. Ensrud KE, Palermo L, Black D, Cauley J, Jergas M, Orwoll ES, Nevitt MC, Fox KM, Cummings SR. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res. 1995 Nov; 10(11):1778-87. PMID: 8592956.
      View in: PubMed
    197. Boyd M, Harris F, McFarlane R, Davidson HR, Black D. A human BRCA1 gene knockout. Nature. 1995 Jun 15; 375(6532):541-2. PMID: 7791869.
      View in: PubMed
    198. Black D, Palermo L, Nevitt MC, Genant HK, Epstein R, San Valentin R, Cummings SR. Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures. J Bone Miner Res. 1995 Jun; 10(6):890-902. PMID: 7572313.
      View in: PubMed
    199. Black D. Why elderly women should be screened and treated to prevent osteoporosis. Am J Med. 1995 Feb 27; 98(2A):67S-75S. PMID: 7709939.
      View in: PubMed
    200. Nevitt MC, Johnell O, Black D, Ensrud K, Genant HK, Cummings SR. Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int. 1994 Nov; 4(6):325-31. PMID: 7696827.
      View in: PubMed
    201. Ettinger B, Black D, Palermo L, Nevitt MC, Melnikoff S, Cummings SR. Kyphosis in older women and its relation to back pain, disability and osteopenia: the study of osteoporotic fractures. Osteoporos Int. 1994 Jan; 4(1):55-60. PMID: 8148573.
      View in: PubMed
    202. Suman VJ, Atkinson EJ, O'Fallon WM, Black D, Melton LJ. A nomogram for predicting lifetime hip fracture risk from radius bone mineral density and age. Bone. 1993 Nov-Dec; 14(6):843-6. PMID: 8155407.
      View in: PubMed
    203. Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black D, Tao JL, Cummings SR. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1993 May 1; 118(9):657-65. PMID: 8460853.
      View in: PubMed
    204. Cummings SR, Black D, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9; 341(8837):72-5. PMID: 8093403.
      View in: PubMed
    205. Black D, Reiss TF, Nevitt MC, Cauley J, Karpf D, Cummings SR. Design of the Fracture Intervention Trial. Osteoporos Int. 1993; 3 Suppl 3:S29-39. PMID: 8298200.
      View in: PubMed
    206. Siegel D, Cheitlin MD, Seeley DG, Black D, Hulley SB. Silent myocardial ischemia in men with systemic hypertension and without clinical evidence of coronary artery disease. Am J Cardiol. 1992 Jul 1; 70(1):86-90. PMID: 1615875.
      View in: PubMed
    207. Black D, Cummings SR, Melton LJ. Appendicular bone mineral and a woman's lifetime risk of hip fracture. J Bone Miner Res. 1992 Jun; 7(6):639-46. PMID: 1414482.
      View in: PubMed
    208. Black D, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res. 1992 Jun; 7(6):633-8. PMID: 1414481.
      View in: PubMed
    209. Steiger P, Cummings SR, Black D, Spencer NE, Genant HK. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res. 1992 Jun; 7(6):625-32. PMID: 1414480.
      View in: PubMed
    210. Ettinger B, Black D, Nevitt MC, Rundle AC, Cauley JA, Cummings SR, Genant HK. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1992 Apr; 7(4):449-56. PMID: 1535172.
      View in: PubMed
    211. Nevitt MC, Cummings SR, Browner WS, Seeley DG, Cauley JA, Vogt TM, Black D. The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol. 1992 Mar 1; 135(5):490-9. PMID: 1570815.
      View in: PubMed
    212. Siegel D, Hulley SB, Black D, Cheitlin MD, Sebastian A, Seeley DG, Hearst N, Fine R. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992 Feb 26; 267(8):1083-9. PMID: 1735925.
      View in: PubMed
    213. Siegel D, Black D, Seeley DG, Hulley SB. Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol. 1992 Feb 1; 69(4):344-7. PMID: 1734646.
      View in: PubMed
    214. Black D, Cummings SR, Stone K, Hudes E, Palermo L, Steiger P. A new approach to defining normal vertebral dimensions. J Bone Miner Res. 1991 Aug; 6(8):883-92. PMID: 1785377.
      View in: PubMed
    215. Rubin SM, Sidney S, Black D, Browner WS, Hulley SB, Cummings SR. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med. 1990 Dec 15; 113(12):916-20. PMID: 2240916.
      View in: PubMed
    216. Cauley JA, Cummings SR, Black D, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990 Nov; 163(5 Pt 1):1438-44. PMID: 2240084.
      View in: PubMed
    217. Guydish JR, Abramowitz A, Woods W, Black D, Sorensen JL. Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health. 1990 Aug; 80(8):995-7. PMID: 2368868; PMCID: PMC1404792.
    218. Siegel D, Cheitlin MD, Black D, Seeley D, Hearst N, Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol. 1990 Mar 15; 65(11):742-7. PMID: 2138408.
      View in: PubMed
    219. Cummings SR, Black D, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA. 1990 Feb 2; 263(5):665-8. PMID: 2404146.
      View in: PubMed
    220. Cummings SR, Black D, Rubin SM. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med. 1989 Nov; 149(11):2445-8. PMID: 2818106.
      View in: PubMed
    221. Lande WM, Andrews DL, Clark MR, Braham NV, Black D, Embury SH, Mentzer WC. The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability. Blood. 1988 Dec; 72(6):2056-9. PMID: 3196878.
      View in: PubMed
    222. Fenoll C, Black D, Howell SH. The intergenic region of maize streak virus contains promoter elements involved in rightward transcription of the viral genome. EMBO J. 1988 Jun; 7(6):1589-96. PMID: 16453851.
      View in: PubMed
    223. Black D, Daniels AU, Dunn HK, Kruger RA. Computerized tomographic determination of vertebral density after total hip arthroplasty. Clin Orthop Relat Res. 1985 Sep; (198):259-63. PMID: 4028558.
      View in: PubMed
    224. Grunbaum BW, Selvin S, Pace N, Black D. Frequency distribution and discrimination probability of twelve protein genetic variants in human blood as functions of race, sex, and age. J Forensic Sci. 1978 Jul; 23(3):577-87. PMID: 744988.
      View in: PubMed
    Dennis's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP